Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction

BACKGROUND: Angiotensin receptor–neprilysin inhibitor (ARNI) therapy has been associated with improved survival for patients with symptomatic heart failure and reduced ejection fraction (HFrEF). OBJECTIVES: We performed a meta-analysis of arrhythmia endpoints from studies comparing ARNI with angiote...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Amanda D.F., Fernandes, Gilson C., Ternes, Caique M.P., Cardoso, Rhanderson, Chaparro, Sandra V., Goldberger, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Arrhythmic Risk in Cardiomyopathy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710618/
https://www.ncbi.nlm.nih.gov/pubmed/34988523
http://dx.doi.org/10.1016/j.hroo.2021.09.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710618/
https://www.ncbi.nlm.nih.gov/pubmed/34988523
http://dx.doi.org/10.1016/j.hroo.2021.09.009

Ejemplares similares